Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 15;8(6):839-849.
doi: 10.3945/an.117.016568. Print 2017 Nov.

Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota

Affiliations
Review

Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota

Julia K Bird et al. Adv Nutr. .

Abstract

Encouraging scientific research into the health effects of dietary bioactive resveratrol has been confounded by its rapid first-pass metabolism, which leads to low in vivo bioavailability. Preliminary studies have shown that resveratrol can modulate gut microbiota composition, undergo biotransformation to active metabolites via the intestinal microbiota, or affect gut barrier function. In rodents, resveratrol can modify the relative Bacteroidetes:Firmicutes ratio and reverse the gut microbial dysbiosis caused by a high-fat diet. By upregulating the expression of genes involved in maintaining tight junctions between intestinal cells, resveratrol contributes to gut barrier integrity. The composition of the gut microbiome and rapid metabolism of resveratrol determines the production of resveratrol metabolites, which are found at greater concentrations in humans after ingestion than their parent molecule and can have similar biological effects. Resveratrol may affect cardiovascular risk factors such as elevated blood cholesterol or trimethylamine N-oxide concentrations. Modulating the composition of the gut microbiota by resveratrol may affect central energy metabolism and modify concentrations of satiety hormones to produce antiobesity effects. Encouraging research from animal models could be tested in humans.

Keywords: cardiovascular disease; gut barrier integrity; inflammation; microbiome; obesity; resveratrol.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: JKB, DR, PW, and RES are employees of DSM Nutritional Products, a supplier of nutritional ingredients, including resveratrol, for use in food, dietary supplements, pharmaceutic applications, and animal feed.

Figures

FIGURE 1
FIGURE 1
The metabolism and disposition of RES. RES is mainly absorbed in the small intestine after oral intake. It is then quickly and extensively metabolized to RES-GLU and RES-SUL forms in the intestine and the liver. The RES-GLU and RES-SUL forms are excreted by the kidney in the urine. In the human body, sulfatases and glucuronidases can convert the conjugated forms of RES back to the free RES form. Enterohepatic recycling also occurs by biliary excretion and intestinal reabsorption. Moreover, in the intestine, unabsorbed RES is converted to microbial metabolites—for example, DHR—which can also be further metabolized to DHR-GLU and DHR-SUL derivatives. Finally, the unabsorbed RES and its metabolites are excreted in the feces. DHR, dihydroresveratrol; GLU, glucuronide; RES, resveratrol; SUL, sulfate.

Similar articles

Cited by

References

    1. Rothwell JA, Perez-Jimenez J, Neveu V, Medina-Remón A, M'Hiri N, García-Lobato P, Manach C, Knox C, Eisner R, Wishart DS, et al. Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database (Oxford) 2013;2013:bat070. - PMC - PubMed
    1. Most J, Tosti V, Redman LM, Fontana L. Calorie restriction in humans: an update. Ageing Res Rev 2017;39:36–45. - PMC - PubMed
    1. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191–6. - PubMed
    1. Poulsen MM, Jorgensen JO, Jessen N, Richelsen B, Pedersen SB. Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci 2013;1290:74–82. - PubMed
    1. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337–42. - PMC - PubMed

MeSH terms